SCHEMBL5535758

SCHEMBL5535758

CC(C)C(C)(C)C(=O)Nc1ccc(NS(C)(=O)=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.52
KDM4E B2RXH2 3/20 0.52
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
NR3C2 P08235 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
ADRB2 P07550 2/20 0.43
ADRB1 P08588 2/20 0.43
ADRB3 P13945 2/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11922959 0.83 L3MBTL1 (0.70) LMNAKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL2746245 0.80 CA12 (0.50) LMNAKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL20642257 0.78 CA1 (0.59) LMNAKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL5542466 0.78 PDK1 (0.56) LMNAL3MBTL1ALDH1A1MAPTSMN1; SMN2
SCHEMBL3047342 0.77 ALDH1A1 (0.47) LMNAKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL12206007 0.77 HPGD (0.49) LMNAKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL5542669 0.75 HSD17B10 (0.51) LMNAKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL6816043 0.75 CYP17A1 (0.49) LMNAKDM4EALDH1A1MAPTSMN1; SMN2
SCHEMBL3047347 0.74 HPGD (0.49) LMNAKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL19329702 0.73 KEAP1 (0.59) LMNAKDM4ENPSR1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed